IMC Chicago’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $89.3M | Buy |
742,500
+20,400
| +3% | +$2.36M | 0.03% | 326 |
|
|
2025
Q4 | $76M | Sell |
722,100
-72,400
| -9% | -$6.8M | 0.03% | 361 |
|
|
2025
Q3 | $66.7M | Buy |
794,500
+186,900
| +31% | +$15.4M | 0.02% | 380 |
|
|
2025
Q2 | $48.1M | Buy |
607,600
+6,500
| +1% | +$517K | 0.02% | 395 |
|
|
2025
Q1 | $54M | Buy |
601,100
+151,100
| +34% | +$14.1M | 0.03% | 311 |
|
|
2024
Q4 | $44.8M | Buy |
450,000
+78,100
| +21% | +$8.05M | 0.02% | 376 |
|
|
2024
Q3 | $42.2M | Buy |
371,900
+45,700
| +14% | +$5.43M | 0.02% | 343 |
|
|
2024
Q2 | $40.4M | Sell |
326,200
-83,600
| -20% | -$10.8M | 0.02% | 339 |
|
|
2024
Q1 | $54.1M | Buy |
409,800
+225,600
| +122% | +$27.8M | 0.03% | 235 |
|
|
2023
Q4 | $20.1M | Buy |
184,200
+5,300
| +3% | +$550K | 0.01% | 456 |
|
|
2023
Q3 | $18.4M | Sell |
178,900
-20,900
| -10% | -$2.25M | 0.02% | 402 |
|
|
2023
Q2 | $23.1M | Sell |
199,800
-31,700
| -14% | -$3.6M | 0.02% | 346 |
|
|
2023
Q1 | $24.6M | Sell |
231,500
-188,700
| -45% | -$20.4M | 0.03% | 289 |
|
|
2022
Q4 | $46.6M | Buy |
420,200
+126,300
| +43% | +$12.9M | 0.07% | 168 |
|
|
2022
Q3 | $25.3M | Sell |
293,900
-94,100
| -24% | -$8.4M | 0.03% | 246 |
|
|
2022
Q2 | $35.4M | Buy |
388,000
+77,800
| +25% | +$6.9M | 0.05% | 180 |
|
|
2022
Q1 | $25.5M | Buy |
+310,200
| New | +$24.5M | 0.03% | 300 |
|
|
2021
Q4 | – | Sell |
-519,700
| Closed | -$19.7M | – | 1262 |
|
|
2021
Q3 | $19.7M | Buy |
519,700
+254,600
| +96% | +$19.4M | 0.02% | 358 |
|
|
2021
Q2 | $7.4M | Sell |
265,100
-22,262
| -8% | -$1.66M | 0.01% | 512 |
|
|
2021
Q1 | $21.1M | Buy |
287,362
+73,570
| +34% | +$5.43M | 0.03% | 278 |
|
|
2020
Q4 | $16.7M | Buy |
213,792
+57,221
| +37% | +$4.38M | 0.02% | 305 |
|
|
2020
Q3 | $12.4M | Buy |
156,571
+89,394
| +133% | +$7M | 0.02% | 280 |
|
|
2020
Q2 | $4.96M | Sell |
67,177
-77,866
| -54% | -$5.86M | 0.01% | 379 |
|
|
2020
Q1 | $10.6M | Sell |
145,043
-71,998
| -33% | -$5.66M | 0.02% | 209 |
|
|
2019
Q4 | $18.8M | Sell |
217,041
-4,611
| -2% | -$379K | 0.05% | 139 |
|
|
2019
Q3 | $17.8M | Buy |
221,652
+88,032
| +66% | +$7.06M | 0.06% | 121 |
|
|
2019
Q2 | $10.7M | Buy |
133,620
+36,680
| +38% | +$2.81M | 0.03% | 165 |
|
|
2019
Q1 | $7.69M | Sell |
96,940
-23,161
| -19% | -$1.73M | 0.03% | 178 |
|
|
2018
Q4 | $8.76M | Buy |
+120,101
| New | +$8.48M | 0.03% | 135 |
|
Other funds holding MRK
VCM
VPM
IMC Chicago's MRK Position: Q4 2025 in Review
IMC Chicago sold out of Merck (MRK) in Q4 2025, closing a stake of 19,187 shares — an estimated $1.8M sold.
IMC Chicago first reported a position in MRK in Q2 2019 and held it in 7 quarters. The position peaked at $4.35M in Q4 2019. 3,651 funds tracked by Wall St. Rank hold MRK as of Q4 2025.
- IMC Chicago reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
- IMC Chicago sold 19,187 Merck shares in Q4 2025, an estimated $1.8M.
- IMC Chicago first reported a position in Merck in Q2 2019 and held it in 7 quarters.
- IMC Chicago's Merck position peaked at $4.35M in Q4 2019.
- 3,651 funds tracked by Wall St. Rank held Merck as of Q4 2025.
Based on IMC Chicago's 13F filing for Q4 2025, filed 29 Jan 2026.